Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: the MAGSTEMI …

M Sabate, F Alfonso, A Cequier, S Romani, P Bordes… - Circulation, 2019 - Am Heart Assoc
… This investigator-driven, multicenter, randomized, single-… requiring primary percutaneous
coronary intervention have the … been associated with clinical outcomes after PLLA-based BRS. …

… , randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold …

RA Byrne, F Alfonso, S Schneider… - European heart …, 2019 - academic.oup.com
… We did a prospective, randomized, multicentre, non-inferiority… providing short-term coronary
artery scaffolding and drug … in patients with ST-segment elevation myocardial infarction: …

[HTML][HTML] Bioresorbable scaffolds vs. drug-eluting stents on short-and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis

Y Wan, D Wang, W Deng, S Lai… - Frontiers in Cardiovascular …, 2022 - frontiersin.org
… ), target vessel myocardial infarction (TVMI), and cardiac death. … All the trials were multicenter,
except for the EVERBIO II trial, … outcomes of BRS implantation at short- and mid-term follow-…

Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-Segment Elevation Myocardial Infarction: Rationale, Design, and Methodology …

CO Fallesen, A Maehara, L Antonsen… - Cardiology, 2021 - karger.com
… on midterm healing properties of the magnesium BRS in … The magnesium scaffold was
initially associated with a short … from Infraredx with a TVC Insight Imaging catheter, which is a …

Current perspectives on bioresorbable scaffolds in coronary intervention and other fields

X Wu, S Wu, H Kawashima, H Hara, M Ono… - Expert review of …, 2021 - Taylor & Francis
… questioned after the results from the clinical trial of multi-center … Post-PCI and midterm
outcomes following BRS treated the … (n = 50) with de novo lesions underwent non-ST segment

Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI …

E Moscarella, G Campo, M Leoncini… - … of Cardiovascular …, 2022 - journals.lww.com
… Randomized trials comparing Absorb bioresorbable vascular scaffold (BVS) with everolimus…
1–3 but similar outcomes over the long term. The poor early results have been attributed to …

[HTML][HTML] Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study

T Lhermusier, P Ohayon, N Boudou, F Bouisset… - Trials, 2019 - Springer
Patients with ST segment elevation myocardial infarction (STEMI) who underwent primary
percutaneous coronary interventionartery disease patients at mid-term and long-term follow-…

… everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction

P Desperak, M Hawranek, P Chodór… - … Cardiology/Postępy w …, 2020 - termedia.pl
… elevation myocardial infarction: a prospective multicentre study ‘… Immediate and midterm
outcomes following primary PCI with … with ST-segment myocardial infarction: insights from the …

[HTML][HTML] Bioresorbable scaffolds: contemporary status and future directions

X Peng, W Qu, Y Jia, Y Wang, B Yu… - Frontiers in Cardiovascular …, 2020 - frontiersin.org
… a composite of cardiac death, myocardial infarction, and target … a prospective multicenter
study enrolling 16 patients with de … revealed the 2 year outcomes after implantation. In the seven …

Long-term outcomes following bioresorbable vascular scaffolds

K Miyashita, K Ninomiya, A Tobe… - … of Cardiovascular …, 2024 - Taylor & Francis
… This review summaries the lessons learned from the first-… mainly driven by target vessel
myocardial infarction (TV-MI, 6% vs 1… The first multicentre study was conducted in 50 patients and …